Levodopa Is a Double-Edged Sword for Balance and Gait in People With Parkinson's Disease

Movement Disorders

Volumn 30, Issue 10, 2015, Pages 1361-1370

  Curtze, Carolin ^a   Nutt, John G ^a   Carlson Kuhta, Patricia ^a   Mancini, Martina ^a   Horak, Fay B ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Balance; Gait; Inertial sensors; Levodopa; Parkinson's disease

Indexed keywords

LEVODOPA; ANTIPARKINSON AGENT;

ADULT; AGED; ARTICLE; BODY EQUILIBRIUM; BODY SIZE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DYSKINESIA; FEMALE; GAIT; HUMAN; LEVODOPA-INDUCED DYSKINESIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; RANGE OF MOTION; STANDING; TREATMENT RESPONSE; UNIFIED PARKINSON DISEASE RATING SCALE; WALKING; DRUG EFFECTS; EXERCISE TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; EXERCISE TEST; FEMALE; GAIT; HUMANS; LEVODOPA; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PARKINSON DISEASE; POSTURAL BALANCE; SEVERITY OF ILLNESS INDEX;

EID: 84941191166     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26269     Document Type: Article

References (37)

1. Rochester L, Baker K, Nieuwboer A, Burn D. Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson's disease: selective responses to internal and external cues. Mov Disord 2011;26:430-435.
2. Rocchi L, Chiari L, Horak FB. Effects of deep brain stimulation and levodopa on postural sway in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002;73:267-274.
3. Beuter A, Hernandez R, Rigal R, Modolo J, Blanchet P. Postural sway and effect of levodopa in early Parkinson's disease. Can J Neurol Sci 2008;35:65-68.
4. Delval A, Tard C, Defebvre L. Why we should study gait initiation in Parkinson's disease. Neurophysiol Clin 2014;44:69-76.
5. Hong M, Earhart GM. Effects of medication on turning deficits in individuals with Parkinson's disease. J Neurol Phys Ther 2010;34:11-16.
6. Jahn K, Deutschlander A, Stephan T, et al. Imaging human supraspinal locomotor centers in brainstem and cerebellum. NeuroImage 2008;39:786-792.
7. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39.
8. Mancini M, King L, Salarian A, Holmstrom L, McNames J, Horak FB. Mobility lab to assess balance and gait with synchronized body-worn sensors. J Bioeng Biomed Sci 2011;Suppl. 1:007.
9. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
10. Guy W. The Clinical Global Impression Scale. In: ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: U.S. Department of Health; 1976:533-537.
11. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649-2653.
12. Powell LE, Myers AM. The Activities-specific Balance Confidence (ABC) Scale. J Gerontol Med Sci 1995;50:M28-M34.
13. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 1997;26:353-357.
14. Mancini M, Salarian A, Carlson-Kuhta P, et al. ISway: a sensitive, valid and reliable measure of postural control. J Neuroeng Rehabil 2012;9:59.
15. Mancini M, Zampieri C, Carlson-Kuhta P, Chiari L, Horak FB. Anticipatory postural adjustments prior to step initiation are hypometric in untreated Parkinson's disease: an accelerometer-based approach. Eur J Neurol 2009;16:1028-1034.
16. Salarian A, Zampieri C, Horak FB, Carlson-Kuhta P, Nutt JG, Aminian K. Analyzing 180 degrees turns using an inertial system reveals early signs of progression of Parkinson's disease. Conf Proc IEEE Eng Med Biol Soc 2009;2009:224-227.
17. Salarian A, Russmann H, Vingerhoets FJ, Dehollaini C, Blanc Y, Burkhard PR, et al. Gait assessment in Parkinson's disease: toward an ambulatory system for long-term monitoring. IEEE Trans Biomed Eng 2004;51:1434-1443.
18. Lord S, Galna B, Verghese J, Coleman S, Burn D, Rochester L. Independent domains of gait in older adults and associated motor and nonmotor attributes: validation of a factor analysis approach. J Gerontol Med Sci 2013 Jul;68:820-827.
19. Lord S, Galna B, Rochester L. Moving forward on gait measurement: toward a more refined approach. Mov Disord 2013;28:1534-1543.
20. Rocchi L, Chiari L, Cappello A, Horak FB. Identification of distinct characteristics of postural sway in Parkinson's disease: a feature selection procedure based on principal component analysis. Neurosci Lett 2006;394:140-145.
21. Bohnen NI, Albin RL. The cholinergic system and Parkinson disease. Behav Brain Res 2011;221:564-573.
22. Fling BW, Cohen RG, Mancini M, Nutt JG, Fair DA, Horak FB. Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gait. Brain 2013;136:2405-2418.
23. Blin O, Ferrandez AM, Pailhous J, Serratrice G. Dopa-sensitive and dopa-resistant gait parameters in Parkinson's disease. J Neurol Sci 1991;103:51-54.
24. Pavese N, Evans AH, Tai YF, et al. Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET study. Neurology 2006;67:1612-1617.
25. Frenklach A, Louie S, Koop MM, Bronte-Stewart H. Excessive postural sway and the risk of falls at different stages of Parkinson's disease. Mov Disord 2009;24:377-385.
26. Horak FB, Nutt JG, Nashner LM. Postural inflexibility in parkinsonian subjects. J Neurol Sci 1992;111:46-58.
27. Chung KA, Lobb BM, Nutt JG, McNames J, Horak F. Objective measurement of dyskinesia in Parkinson's disease using a force plate. Mov Disord 2010;25:602-608.
28. Massion J. Movement, posture and equilibrium: interaction and coordination. Prog Neurobiol 1992;38:35-56.
29. Ashburn A, Stack E, Pickering RM, Ward CD. A community-dwelling sample of people with Parkinson's disease: characteristics of fallers and non-fallers. Age Ageing 2001;30:47-52.
30. Paul SS, Sherrington C, Canning CG, Fung VS, Close JC, Lord SR. The relative contribution of physical and cognitive fall risk factors in people with Parkinson's disease: a large prospective cohort study. Neurorehabil Neural Repair 2014;28:282-290.
31. Schrag A, Quinn N. Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study. Brain 2000;123(Pt 11):2297-2305.
32. Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010;362:2077-2091.
33. St George RJ, Carlson-Kuhta P, Burchiel KJ, Hogarth P, Frank N, Horak FB. The effects of subthalamic and pallidal deep brain stimulation on postural responses in patients with Parkinson disease. J Neurosurg 2012;116:1347-1356.
34. Zampieri C, Salarian A, Carlson-Kuhta P, Aminian K, Nutt JG, Horak FB. The instrumented timed up and go test: potential outcome measure for disease modifying therapies in Parkinson's disease. J Neurol Neurosurg Psychiatry 2010;81:171-176.
35. Mancini M, Carlson-Kuhta P, Zampieri C, Nutt JG, Chiari L, Horak FB. Postural sway as a marker of progression in Parkinson's disease: a pilot longitudinal study. Gait Posture 2012;36:471-476.
36. Maetzler W, Domingos J, Srulijes K, Ferreira JJ, Bloem BR. Quantitative wearable sensors for objective assessment of Parkinson's disease. Mov Disord 2013;28:1628-1637.
37. Hof AL. Scaling gait data to body size. Gait Posture 1996;4:222-223.